Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-03-04 @ 7:35 AM
Study NCT ID:
NCT01650350
Status:
TERMINATED
Last Update Posted:
2022-03-04
First Post:
2012-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
Sponsor:
Brown University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-24
First Submit QC Date:
None
Study First Post Date:
2012-07-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-14
Results First Submit QC Date:
None
Results First Post Date:
2015-07-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-23
Last Update Post Date:
2022-03-04
Last Update Post Date Type:
ACTUAL